GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 1 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139 | +9.4% | 80,535 | +24.4% | 0.00% | – |
| Q2 2023 | $127 | -3.1% | 64,735 | +38.0% | 0.00% | – |
| Q1 2023 | $131 | +1.6% | 46,900 | +25.7% | 0.00% | – |
| Q4 2022 | $129 | -99.9% | 37,300 | 0.0% | 0.00% | – |
| Q3 2022 | $96,000 | +6.7% | 37,300 | 0.0% | 0.00% | – |
| Q2 2022 | $90,000 | -46.7% | 37,300 | -9.2% | 0.00% | – |
| Q1 2022 | $169,000 | -54.6% | 41,099 | +41.9% | 0.00% | – |
| Q4 2021 | $372,000 | +10.7% | 28,956 | -7.0% | 0.00% | – |
| Q3 2021 | $336,000 | -81.9% | 31,144 | -84.7% | 0.00% | – |
| Q2 2021 | $1,861,000 | -36.6% | 203,870 | -34.6% | 0.00% | – |
| Q1 2021 | $2,937,000 | +19.0% | 311,495 | -16.2% | 0.00% | – |
| Q2 2020 | $2,468,000 | +4.1% | 371,757 | -8.7% | 0.00% | – |
| Q1 2020 | $2,371,000 | +32.3% | 407,322 | +103.9% | 0.00% | – |
| Q4 2019 | $1,792,000 | – | 199,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |